XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 28, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The table below presents components of stock-based compensation expense within the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income:
Thirty-nine Weeks Ended
in thousandsSeptember 28, 2023September 29, 2022
General and administrative$18,927 $16,911 
Selling and store operating1,409 318 
Total stock-based compensation expense$20,336 $17,229 
Stock Option Activity
The table below summarizes stock option activity for the thirty-nine weeks ended September 28, 2023.
OptionsWeighted Average Exercise Price
Outstanding at December 30, 2022
2,101,559 $27.10 
Exercised(336,061)$23.53 
Forfeited or expired(3,983)$48.97 
Outstanding at September 28, 2023
1,761,515 $27.73 
Vested and exercisable at September 28, 2023
1,669,036 $25.39 
Restricted Stock Unit Activity
The following table summarizes restricted stock unit activity during the thirty-nine weeks ended September 28, 2023:
Restricted Stock Units
Service-basedPerformance-basedTotal shareholder returnTotal Restricted Stock Units
Unvested at December 30, 2022408,829 36,117 — 444,946 
Granted374,685 188,543 58,854 622,082 
Vested(132,432)— — (132,432)
Forfeited(24,262)(36,117)— (60,379)
Unvested at September 28, 2023626,820 188,543 58,854 874,217 
Schedule of Valuation Assumptions The grant-date fair value of TSR awards is estimated using a Monte Carlo valuation method, which included the following assumptions for TSR awards granted during the period:
Thirty-nine Weeks Ended
September 28, 2023
Expected term (in years)2.8
Risk-free interest rate4.5 %
Expected volatility49.5 %
Dividend yield— %
Restricted Stock Award Activity
The following table summarizes restricted stock award activity during the thirty-nine weeks ended September 28, 2023:
Restricted Stock Awards
Service-basedPerformance-based (1)Total shareholder return (1)Total Restricted Stock Awards
Unvested at December 30, 2022103,326 134,318 87,517 325,161 
Vested(68,334)(86,656)(56,461)(211,451)
Unvested at September 28, 202334,992 47,662 31,056 113,710 
(1) The performance-based and total shareholder return restricted stock awards that vested during the period were issued at 100% of target based on achievement of the predetermined performance and total shareholder return criteria as specified in the underlying grant agreements.